BAFNA PHARMACEUTICALS LTD (BAFNAPH)

NSE: ₹160.31
BSE: ₹162.50
Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
No financial data available for Consolidated.

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2020
Revenue from Operations 42.47
YOY Revenue Growth % -
Other Income 0.26
Total Income 42.73
Total Expenses + 44.47
Cost of Materials Consumed 30.24
Employee Benefit Expense 10.25
Other Expenses 3.97
Operating Profit -2.00
OPM % -4.7%
Profit Before Exceptional -1.88
Exceptional Items -22.56
Profit Before Tax + -24.44
Tax Expense 0.29
Tax % -
Profit After Tax -24.73
EPS (Basic) -15.52

Balance Sheet

Particulars Mar 2020
ASSETS
Non-Current Assets + 0.00
Property, Plant & Equipment 0.00
Capital Work in Progress 0.00
Non-Current Investments 0.00
Goodwill 0.00
Other Intangible Assets 0.00
Current Assets + 0.00
Inventories 0.00
Trade Receivables 0.00
Cash and Cash Equivalents 0.00
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 0.00
Other Equity 0.00
Non-Current Liabilities 0.00
Current Liabilities 0.00
Total Liabilities 0.00

Cash Flow Statement

Particulars Mar 2020
Cash from Operating Activities 0.00
Cash from Investing Activities 0.00
Cash from Financing Activities 0.00
Net Increase/Decrease in Cash 0.00